These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21761486)

  • 21. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An introduction to induced pluripotent stem cells.
    Hanley J; Rastegarlari G; Nathwani AC
    Br J Haematol; 2010 Oct; 151(1):16-24. PubMed ID: 20666774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Returning to the stem state: epigenetics of recapitulating pre-differentiation chromatin structure.
    Shafa M; Krawetz R; Rancourt DE
    Bioessays; 2010 Sep; 32(9):791-9. PubMed ID: 20652894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage.
    Li F; Bronson S; Niyibizi C
    J Cell Biochem; 2010 Mar; 109(4):643-52. PubMed ID: 20039314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concise review: non-cell autonomous reprogramming: a nucleic acid-free approach to induction of pluripotency.
    Parameswaran S; Balasubramanian S; Rao MS; Ahmad I
    Stem Cells; 2011 Jul; 29(7):1013-20. PubMed ID: 21544901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reprogramming with defined factors: from induced pluripotency to induced transdifferentiation.
    Masip M; Veiga A; Izpisúa Belmonte JC; Simón C
    Mol Hum Reprod; 2010 Nov; 16(11):856-68. PubMed ID: 20616150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.
    Li Y; Geng YJ
    Growth Horm IGF Res; 2010 Dec; 20(6):391-8. PubMed ID: 20956084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concise review: alchemy of biology: generating desired cell types from abundant and accessible cells.
    Pournasr B; Khaloughi K; Salekdeh GH; Totonchi M; Shahbazi E; Baharvand H
    Stem Cells; 2011 Dec; 29(12):1933-41. PubMed ID: 21997905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced pluripotent stem cells: an emerging theranostics platform.
    Nelson TJ; Terzic A
    Clin Pharmacol Ther; 2011 May; 89(5):648-50. PubMed ID: 21512525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide reprogramming in hybrids of somatic cells and embryonic stem cells.
    Ambrosi DJ; Tanasijevic B; Kaur A; Obergfell C; O'Neill RJ; Krueger W; Rasmussen TP
    Stem Cells; 2007 May; 25(5):1104-13. PubMed ID: 17272499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
    Romano G
    Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reprogramming adult hematopoietic cells.
    Kaneko S; Otsu M; Nakauchi H
    Curr Opin Hematol; 2010 Jul; 17(4):271-5. PubMed ID: 20571391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: insights from experimental models.
    Kong CW; Akar FG; Li RA
    Thromb Haemost; 2010 Jul; 104(1):30-8. PubMed ID: 20539906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human pluripotent stem cells in drug discovery and predictive toxicology.
    Laustriat D; Gide J; Peschanski M
    Biochem Soc Trans; 2010 Aug; 38(4):1051-7. PubMed ID: 20659002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases].
    Ito D; Yagi T; Suzuki N
    Brain Nerve; 2013 Mar; 65(3):283-8. PubMed ID: 23475520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic sulfonyl-hydrazone-1 positively regulates cardiomyogenic microRNA expression and cardiomyocyte differentiation of induced pluripotent stem cells.
    Quattrocelli M; Palazzolo G; Agnolin I; Martino S; Bouché M; Anastasia L; Sampaolesi M
    J Cell Biochem; 2011 Aug; 112(8):2006-14. PubMed ID: 21445862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced pluripotent stem cells: progress towards a biomedical application.
    Barile L; Altomare C; Zaza A
    Expert Rev Cardiovasc Ther; 2011 Oct; 9(10):1265-9. PubMed ID: 21985539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming.
    Li W; Ding S
    Trends Pharmacol Sci; 2010 Jan; 31(1):36-45. PubMed ID: 19896224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. iPS cell technology in regenerative medicine.
    Lengner CJ
    Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.